Progress in epidermolysis bullosa: Summary of a workshop in CILAD-2010

Julio Cesar Salas-Alanis, Rodrigo Cepeda-Valdes, Jemima E. Mellerio, Angela M. Christiano, Jouni Uitto

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background Epidermolysis bullosa (EB), a group of blistering disorders, manifests with fragility of skin and mucous membranes, with considerable phenotypic variability. As many as 15 distinct genes have been shown to harbor mutations inheritable forms of EB. The types and combinations of mutations in these genes and their consequences at the mRNA and protein levels, when placed on the affected individuals' genetic background and the external trauma, explain the spectrum of phenotypes encountered in this disorder. Methods A group of eminent researchers and physician-scientists convened in Cancún, Mexico, as part of the CILAD-2010 Meeting, to discuss the most recent progress in diagnosis and management of patients with EB, with emphasis on development of novel treatment strategies. Results The information on specific mutations in the candidate genes has been helpful in establishing genotype/phenotype correlations and has formed the basis for prenatal testing and preimplantation of genetic diagnosis for EB. Conclusions In spite of the progress in molecular genetics of EB, there is no specific and effective treatment, and management of these patients continues to present tremendous clinical challenges. This overview summarizes the presentations and discussions in this international workshop. © 2012 The International Society of Dermatology.
Original languageEnglish
Pages (from-to)682-687
Number of pages6
JournalInternational Journal of Dermatology
DOIs
Publication statusPublished - 1 Jun 2012
Externally publishedYes

Fingerprint

Epidermolysis Bullosa
Education
Mutation
Genes
Preimplantation Diagnosis
Genetic Association Studies
Dermatology
Mexico
Molecular Biology
Mucous Membrane
Research Personnel
Physicians
Phenotype
Messenger RNA
Skin
Wounds and Injuries
Therapeutics
Proteins

Cite this

Salas-Alanis, J. C., Cepeda-Valdes, R., Mellerio, J. E., Christiano, A. M., & Uitto, J. (2012). Progress in epidermolysis bullosa: Summary of a workshop in CILAD-2010. International Journal of Dermatology, 682-687. https://doi.org/10.1111/j.1365-4632.2011.05130.x
Salas-Alanis, Julio Cesar ; Cepeda-Valdes, Rodrigo ; Mellerio, Jemima E. ; Christiano, Angela M. ; Uitto, Jouni. / Progress in epidermolysis bullosa: Summary of a workshop in CILAD-2010. In: International Journal of Dermatology. 2012 ; pp. 682-687.
@article{badba1f95c114e03b021c34a3c2d6436,
title = "Progress in epidermolysis bullosa: Summary of a workshop in CILAD-2010",
abstract = "Background Epidermolysis bullosa (EB), a group of blistering disorders, manifests with fragility of skin and mucous membranes, with considerable phenotypic variability. As many as 15 distinct genes have been shown to harbor mutations inheritable forms of EB. The types and combinations of mutations in these genes and their consequences at the mRNA and protein levels, when placed on the affected individuals' genetic background and the external trauma, explain the spectrum of phenotypes encountered in this disorder. Methods A group of eminent researchers and physician-scientists convened in Canc{\'u}n, Mexico, as part of the CILAD-2010 Meeting, to discuss the most recent progress in diagnosis and management of patients with EB, with emphasis on development of novel treatment strategies. Results The information on specific mutations in the candidate genes has been helpful in establishing genotype/phenotype correlations and has formed the basis for prenatal testing and preimplantation of genetic diagnosis for EB. Conclusions In spite of the progress in molecular genetics of EB, there is no specific and effective treatment, and management of these patients continues to present tremendous clinical challenges. This overview summarizes the presentations and discussions in this international workshop. {\circledC} 2012 The International Society of Dermatology.",
author = "Salas-Alanis, {Julio Cesar} and Rodrigo Cepeda-Valdes and Mellerio, {Jemima E.} and Christiano, {Angela M.} and Jouni Uitto",
year = "2012",
month = "6",
day = "1",
doi = "10.1111/j.1365-4632.2011.05130.x",
language = "English",
pages = "682--687",
journal = "International Journal of Dermatology",
issn = "0011-9059",
publisher = "Wiley-Blackwell",

}

Progress in epidermolysis bullosa: Summary of a workshop in CILAD-2010. / Salas-Alanis, Julio Cesar; Cepeda-Valdes, Rodrigo; Mellerio, Jemima E.; Christiano, Angela M.; Uitto, Jouni.

In: International Journal of Dermatology, 01.06.2012, p. 682-687.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Progress in epidermolysis bullosa: Summary of a workshop in CILAD-2010

AU - Salas-Alanis, Julio Cesar

AU - Cepeda-Valdes, Rodrigo

AU - Mellerio, Jemima E.

AU - Christiano, Angela M.

AU - Uitto, Jouni

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Background Epidermolysis bullosa (EB), a group of blistering disorders, manifests with fragility of skin and mucous membranes, with considerable phenotypic variability. As many as 15 distinct genes have been shown to harbor mutations inheritable forms of EB. The types and combinations of mutations in these genes and their consequences at the mRNA and protein levels, when placed on the affected individuals' genetic background and the external trauma, explain the spectrum of phenotypes encountered in this disorder. Methods A group of eminent researchers and physician-scientists convened in Cancún, Mexico, as part of the CILAD-2010 Meeting, to discuss the most recent progress in diagnosis and management of patients with EB, with emphasis on development of novel treatment strategies. Results The information on specific mutations in the candidate genes has been helpful in establishing genotype/phenotype correlations and has formed the basis for prenatal testing and preimplantation of genetic diagnosis for EB. Conclusions In spite of the progress in molecular genetics of EB, there is no specific and effective treatment, and management of these patients continues to present tremendous clinical challenges. This overview summarizes the presentations and discussions in this international workshop. © 2012 The International Society of Dermatology.

AB - Background Epidermolysis bullosa (EB), a group of blistering disorders, manifests with fragility of skin and mucous membranes, with considerable phenotypic variability. As many as 15 distinct genes have been shown to harbor mutations inheritable forms of EB. The types and combinations of mutations in these genes and their consequences at the mRNA and protein levels, when placed on the affected individuals' genetic background and the external trauma, explain the spectrum of phenotypes encountered in this disorder. Methods A group of eminent researchers and physician-scientists convened in Cancún, Mexico, as part of the CILAD-2010 Meeting, to discuss the most recent progress in diagnosis and management of patients with EB, with emphasis on development of novel treatment strategies. Results The information on specific mutations in the candidate genes has been helpful in establishing genotype/phenotype correlations and has formed the basis for prenatal testing and preimplantation of genetic diagnosis for EB. Conclusions In spite of the progress in molecular genetics of EB, there is no specific and effective treatment, and management of these patients continues to present tremendous clinical challenges. This overview summarizes the presentations and discussions in this international workshop. © 2012 The International Society of Dermatology.

U2 - 10.1111/j.1365-4632.2011.05130.x

DO - 10.1111/j.1365-4632.2011.05130.x

M3 - Article

SP - 682

EP - 687

JO - International Journal of Dermatology

JF - International Journal of Dermatology

SN - 0011-9059

ER -